A genome-wide association study confirmed that PNPLA3 is a risk factor for the full histological spectrum of NAFLD at genome-wide significance levels, but also suggested that the Wnt signaling pathway may be relevant in NAFLD pathogenesis [87]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.